Form D · Biotechnology
Carogen Corporaton
Farmington, CT · CIK 0001687042
Offering snapshot reported Oct 11, 2016 · SEC filing
- Reported sold
- $2.08M Offering amount: $3.08M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2016 | Initial | $2,080,159 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-272206
Source: Form D, filed Oct 11, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bijan Almassian | Director, Executive |
| Susan Froshauer | Director |
| Frank Marco | Director |
| Valerian Nakaar | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Cell & Genome Sciences Building 400 Farmington Avenue, Room 2802
Farmington, CT, 06036
Farmington, CT, 06036